Drug
GVAX
Drug Profile
| Therapeutic Class | Immunotherapy |
| Drug Class | Therapeutic Vaccines |
| Group | Therapeutic Vaccines |
| Mechanism of Action | Cell-based vaccine |
Study design
RT–Drug Timing Window
Study design
RT–Drug Timing Window
Data on this page refer exclusively to patients treated with
GVAX combined with SBRT, without concurrent use of
drugs from other classes.
Combination therapy data and pooled group-level evidence are available on the
Therapeutic Vaccines group page.